Hideji Yako

12PUBLICATIONS
7CO-AUTHORS
Nanoscale characterisationNeurology and neuromuscular diseasesBiomaterialsNeural engineeringHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 15, 2026
Modeling NDD-Associated NLGN2 Depletion Using CRISPR/Cas13 Reveals Exaggerated Process Elongation Mediated by the CCDC88A-G Protein-ELMO Axis.

|Aug 13, 2026
Signaling Through Girdin Underlies Excessive Cell Morphogenesis Resulting from Depletion of Neurodevelopmental Disorder-Related Neurexin-2.

|Jun 26, 2026
Hesperetin Rescues Amyloid Beta-Induced Defects in Neurite Outgrowth Under In Vitro Mild Cognitive Impairment-like Cellular Conditions.

|May 04, 2026
The RhoG-Binding Domain of ELMO1 Rescues the PTENopathy-like Phenotype in Oligodendroglial FBD-102b Cells.

|Feb 27, 2026
Hesperetin, Acting Through Inhibition of c-Jun Signaling, Mitigates Hypomyelinating Disease-Associated Stop-Loss Claudin-11-Induced Defective Morphogenesis in Oligodendroglial FBD-102b Cells.

Yuki Miyamoto, Takeru Omata, Yuta Muraki

|Nov 13, 2025
The ErbB2-Dock7 Signaling Axis Mediates Excessive Cell Morphogenesis Induced by Autism Spectrum Disorder- and Intellectual Disability-Associated Sema5A p.Arg676Cys.

Mikito Takahashi, Hideji Yako, Ayaka Suzuki

Pageof 2

Frequent Collaborators

8 joint publications

Junji Yamauchi

7 joint publications

Yuki Miyamoto

5 joint publications

Sookja K Chung

3 joint publications

Akinori Nishi